Home›Search›Journal of Thrombosis and Haemostasis

Journal of Thrombosis and Haemostasis

Elsevier B.V. · Netherlands · Est. 1987

ISSN1538-7836

SJR Q1✓ WOS SCIE✓ Scopus / SJR

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (3 more)+18

Total96

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

Publication speed: not measurable

publisher doesn’t disclose per-article submission dates — we never estimate

SJR Rank

Top 25% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei

2.054

H-Indexi

242

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

1.548

Total Worksi

12,016

Total Citationsi

454,478

2yr Mean Citednessi

2.91

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope✦ Compiled from public sources

The Journal of Thrombosis and Haemostasis advances science related to thrombosis, bleeding disorders, and vascular biology. It covers research on thrombosis and hematology, including basic manuscripts on blood coagulation and fibrinolysis, proteins and reactions, blood platelets, and their interactions with biological systems. Clinical manuscripts can cover venous thrombosis and arterial disease, hemophilia and other bleeding disorders, and platelet diseases.

AI-compiled from public web sources · verify on publisher page →

General Information

Country / RegionNetherlands

Primary LanguageEnglish

1st Year Published1987

FrequencyMonthly

StatusActive (last: 2026)

Total Publications12,016

Publisher OrgElsevier BV

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Elsevier B.V.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1538-7836

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

347

9.7k

2019

513

41k

2020

438

10k

2021

315

4.7k

2022

540

7.2k

2023

395

2.9k

2024

530

1.1k

2025

258

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

HematologyQ1

Medicine (miscellaneous)Q1

Subject Classification

Web of Science Categories

HematologyPeripheral Vascular Diseases

Scopus Categories

HematologyMedicine (miscellaneous)

Research Topics (OpenAlex)

Blood Coagulation and Thrombosis MechanismsVenous Thromboembolism Diagnosis and ManagementPlatelet Disorders and TreatmentsHemophilia Treatment and ResearchBlood properties and coagulationAtrial Fibrillation Management and OutcomesHeparin-Induced Thrombocytopenia and ThrombosisAntiplatelet Therapy and Cardiovascular DiseasesCoagulation, Bradykinin, Polyphosphates, and AngioedemaProtease and Inhibitor Mechanisms

Frequently asked questions about Journal of Thrombosis and Haemostasis

Is Journal of Thrombosis and Haemostasis a predatory journal?

PubScope has no integrity flags on record for Journal of Thrombosis and Haemostasis: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Journal of Thrombosis and Haemostasis?

Journal of Thrombosis and Haemostasis is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.91.

Is Journal of Thrombosis and Haemostasis indexed in Scopus and Web of Science?

Journal of Thrombosis and Haemostasis is indexed in Web of Science, Scopus.